Thomasville National Bank Has $806,000 Position in Cardinal Health, Inc. (NYSE:CAH)

Thomasville National Bank lowered its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 5.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,818 shares of the company’s stock after selling 415 shares during the period. Thomasville National Bank’s holdings in Cardinal Health were worth $806,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Eastern Bank bought a new position in shares of Cardinal Health during the third quarter valued at $25,000. Frazier Financial Advisors LLC increased its position in Cardinal Health by 69.8% in the third quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock worth $28,000 after purchasing an additional 104 shares during the period. Ashton Thomas Private Wealth LLC acquired a new position in shares of Cardinal Health during the 2nd quarter worth about $29,000. Hara Capital LLC acquired a new position in shares of Cardinal Health during the 3rd quarter worth about $31,000. Finally, AM Squared Ltd acquired a new position in shares of Cardinal Health during the 3rd quarter worth about $33,000. 87.17% of the stock is owned by institutional investors.

Cardinal Health Price Performance

NYSE CAH traded down $0.99 on Monday, reaching $120.58. The stock had a trading volume of 322,512 shares, compared to its average volume of 1,985,481. The firm has a fifty day moving average of $119.88 and a two-hundred day moving average of $111.08. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $126.23. The company has a market cap of $29.18 billion, a P/E ratio of 23.46, a price-to-earnings-growth ratio of 1.47 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last released its earnings results on Friday, November 1st. The company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.26. The company had revenue of $52.28 billion for the quarter, compared to analyst estimates of $50.90 billion. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. Cardinal Health’s quarterly revenue was down 4.3% on a year-over-year basis. During the same period in the prior year, the firm posted $1.73 EPS. Research analysts predict that Cardinal Health, Inc. will post 7.82 EPS for the current fiscal year.

Cardinal Health Cuts Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be given a dividend of $0.5056 per share. The ex-dividend date is Thursday, January 2nd. This represents a $2.02 annualized dividend and a dividend yield of 1.68%. Cardinal Health’s dividend payout ratio is currently 39.30%.

Analysts Set New Price Targets

Several research firms have recently issued reports on CAH. StockNews.com lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd. UBS Group boosted their target price on Cardinal Health from $134.00 to $139.00 and gave the stock a “buy” rating in a research report on Monday, November 4th. Bank of America upgraded Cardinal Health from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $132.00 to $145.00 in a research report on Monday, January 6th. Barclays boosted their price objective on Cardinal Health from $117.00 to $133.00 and gave the company an “overweight” rating in a research report on Monday, November 4th. Finally, Morgan Stanley boosted their price objective on Cardinal Health from $127.00 to $136.00 and gave the company an “overweight” rating in a research report on Tuesday, December 17th. Four analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $133.29.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.